Year
2022
Authors
PUYOU DE POUVOURVILLE Gérard, WHITTAL Amanda, JOMMI Claudio, TAYLOR David, ANNEMANS Lieven, SCHOONAERT Lies, VERMEERSCH Sebastian, HUTCHINGS Adam, PATRIS Julien
Abstract
Results: The framework aims to (i) systematically identify and prioritize manufacturer and payer concerns about a new treatment, and (ii) select a mutually acceptable combination of MEA terms that can best address priority concerns, with the lowest possible implementation burden. Conclusions: The proposed framework will be tested in practice, and is a step toward supporting payers and manufacturers to engage in more structured, transparent negotiations to balance the needs of both sides, and enabling quicker, more transparent MEA negotiations and patient access to innovative products.
WHITTAL, A., JOMMI, C., PUYOU DE POUVOURVILLE, G., TAYLOR, D., ANNEMANS, L., SCHOONAERT, L. … PATRIS, J. (2022). Facilitating [corrected] More Efficient Negotiations for Innovative Therapies: A Value-Based Negotiation Framework. International Journal of Technology Assessment in Health Care.